This launch helps us deliver high-quality care with greater convenience for our customers.
Later this year, Grigson and Bunce plan to begin a larger clinical trial of a GLP-1 drug to treat opioid addiction in the outpatient setting
Who Should Use bmiMD
Sermondade N, Huberlant S, Bourhis-Lefebvre V, Arbo E, Gallot V, Colombani M, et al
A class of weight-loss drugs known as glucagon-like peptide-1s (GLP-1s for short) has proven effective, including for Medicare-age people 65 and up, according a meta-analysis by Johns Hopkins University researchers as well as other studies
This may seem like a small amount, but it allows your body to gradually adjust to the medication and minimizes the risk of side effects